ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 303769 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 303769; 2) Community: the network communities that were significantly associated with the response to NSC 303769; 3) Molecule: the relationships between components within communities and NSC 303769; 4) MDR: the compounds that were significantly associated with the NSC 303769.

NSC Compound Enrichment Correlation
NSC 675223 1H-1,2,4-Triazole-5(4H)-one, 4-[[(4-nitrophenyl)methylene] amino]-3-phenyl- 0.00142226725147591 -0.48792493
NSC 382034 2,4-Pyrimidinediamine, 6-ethyl-5-[4-(methylamino)- 3-nitrophenyl]- 0.00159809164939554 0.31754717
NSC 631477 p-Chloranilinum[bis(p-chloraniline)dioxalatoruthenate(III)] 0.00159809164939554 0.39267904
NSC 740 Methotrexate 0.00159809164939554 0.20881284
NSC 650792 1,4,7,10-Tetrathia-13-azacyclopentadecane, 13-[(4-methylphenyl)sulfonyl]- 0.00162803849483077 -0.44357175
NSC 709928 Null 0.00162803849483077 -0.35835966
NSC 740275 5,6-Dihydro-6-(3-morpholinyl-1-propyl)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.00162803849483077 -0.2294924
NSC 673799 Hexanoic acid, 6-[(7-methoxy-1-nitro-9-acridinyl)amino]- 0.00192786276806283 0.28442871
NSC 67480 Null 0.00192786276806283 0.41436408
NSC 711014 Null 0.00192786276806283 0.27185369
Total:60  Current:4    [First] [Prev] [Next] [Last]